ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 87 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,332,000 | -9.8% | 250,800 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,476,000 | -33.8% | 273,893 | -1.9% | 0.00% | -50.0% |
| Q3 2020 | $2,228,000 | -5.6% | 279,193 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $2,359,000 | +2742.2% | 235,707 | +672.8% | 0.00% | – |
| Q1 2020 | $83,000 | +124.3% | 30,500 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | -19.6% | 30,500 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -62.6% | 30,500 | 0.0% | 0.00% | – |
| Q2 2019 | $123,000 | -19.6% | 30,500 | -14.2% | 0.00% | – |
| Q1 2019 | $153,000 | -25.4% | 35,568 | 0.0% | 0.00% | – |
| Q4 2018 | $205,000 | -58.8% | 35,568 | -3.0% | 0.00% | -100.0% |
| Q3 2018 | $497,000 | +10.7% | 36,668 | -3.0% | 0.00% | 0.0% |
| Q2 2018 | $449,000 | +56.4% | 37,796 | -12.1% | 0.00% | – |
| Q4 2017 | $287,000 | – | 42,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |